In murine breast cancer cells, LOX-PP similarly inhibited FGF2 stimulated proliferation and signaling in vitro and xenograft growth in mice, while the Arg152Gln rat variant did not inhibit signaling and inhibited xenograft growth to a lesser degree than Arg152 LOX-PP [43]. This evidence concerns the gene LOX and breast carcinoma.